Mechanism of adenosine inhibition of catecholamine-induced responses in heart.
- 1 February 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 52 (2) , 151-160
- https://doi.org/10.1161/01.res.52.2.151
Abstract
The properties of adenosine inhibition of catecholamine-induced responses were investigated, using an isolated rat heart preparation. Perfusion of hearts with 0.1 microM isoproterenol increased myocardial cAMP content 2.8-fold, activation of cAMP-dependent protein kinase 4.4-fold, phosphorylase a formation 3.4-fold, left ventricular pressure 1.8-fold, rate of ventricular pressure development 2.1-fold, and rate of ventricular relaxation 2.2-fold within 1 minute. When perfused with the isoproterenol, 10 microM adenosine reduced the catecholamine-produced increase in cAMP, cAMP-dependent protein kinase, and phosphorylase by 30-40%, and the elevation in left ventricular pressure and rate of ventricular pressure development by 40-70% within 40 seconds. More than 2 minutes were required for the nucleoside to significantly reduce the isoproterenol-elicited increase in the rate of ventricular relaxation. Perfusion of adenosine alone at concentrations from 0.1 to 10 microM were without effect on the above parameters. Theophylline at 50 microM had no effect alone on the above parameters but blocked the inhibitory actions of adenosine on the isoproterenol-induced responses. In the presence of 15 mM Mg++ adenosine reduced by approximately 56% the 2-fold increase in myocardial membrane adenylate cyclase activity produced by 1 microM isoproterenol without affecting basal or fluoride-stimulated activity. Adenosine also reduced the isoproterenol-induced increase in enzyme activity assayed at 1-2 mM Mg++, a level that more closely approximates the intracellular activity of the ion. The results suggest that physiological concentrations of adenosine attenuate the catecholamine-induced increase in cAMP content, cAMP-dependent protein kinase activation, phosphorylase a formation, and contractile parameters in the working heart, via reducing the beta-adrenergic activation of adenylate cyclase.This publication has 24 references indexed in Scilit:
- Catecholamine-induced phosphorylation of cardiac muscle proteinsBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Adenosine antagonizes the positive inotropic action mediated via β-, but not α-adrenoceptors in the rabbit papillary muscleEuropean Journal of Pharmacology, 1980
- Phosphorylation-Dephosphorylation of EnzymesAnnual Review of Biochemistry, 1979
- Properties of epinephrine-induced activation of cardiac adenosine 3′,5′-monophosphate-dependent protein kinaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Protein kinase-catalyzed membrane phosphorylation and its possible relationship to the role of calcium in the adrenergic regulation of cardiac contractionLife Sciences, 1978
- Modification of relative potencies of beta-adrenoceptor agonists by negative chronotropic agents in rat atriumGeneral Pharmacology: The Vascular System, 1977
- The role of cyclic adenosine 3', 5'-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle.Circulation Research, 1976
- Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: A possible effect on Ca2+ influxJournal of Molecular and Cellular Cardiology, 1975
- Relationship between coronary flow and adenosine production and releaseJournal of Molecular and Cellular Cardiology, 1974
- ADRENERGIC MECHANISMS IN CARDIAC GLYCOGEN METABOLISM*Annals of the New York Academy of Sciences, 1967